Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial (Q92333096)
Jump to navigation
Jump to search
scientific article published on 03 January 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial |
scientific article published on 03 January 2020 |
Statements
Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial (English)
Ziad A Memish
Frederick G Hayden
Ayed Y Asiri
Abdullah M Assiri
Hani A Aziz Jokhdar
Adel Alothman
Hanan H Balkhy
Sameera AlJohani
Shmeylan Al Harbi
Suleiman Kojan
Majed Al Jeraisy
Sameeh Ghazal
Sarah Al Faraj
Asim AlSaedi
Yasser Mandourah
Ghaleb A Al Mekhlafi
Nisreen Murad Sherbeeni
Fatehi Elnour Elzein
Abdullah Almotairi
Ali Al Bshabshe
Ayman Kharaba
Jesna Jose
Abdulrahman Al Harthy
Mohammed Al Sulaiman
Ahmed Mady
Robert A Fowler
Abdulaziz Al-Dawood
Mohamed Abdelzaher
Wail Bajhmom
Mohamed A Hussein
and the Saudi Critical Care Trials group